Overview

Clinical Trial of Efficacy and Safety of the Combination of Reduced Duration Prophylaxis Followed by Immuno-guided Prophylaxis in Lung Transplant Recipients.

Status:
Recruiting
Trial end date:
2023-07-01
Target enrollment:
Participant gender:
Summary
To assess the efficacy of reduced duration prophylaxis followed by immuno-guided prophylaxis to prevent cytomegalovirus disease.
Phase:
Phase 3
Details
Lead Sponsor:
Maimónides Biomedical Research Institute of Córdoba
Collaborator:
Instituto de Salud Carlos III
Treatments:
Ganciclovir
Ganciclovir triphosphate
Valganciclovir